<unk>  of<unk><unk><unk>  (CFS) is variable and uncertain, and the condition is primarily managed rather than cured. Only two<unk> s, cognitive behavioral therapy (CBT) and graded exercise therapy (GET), have demonstrated reproducible evidence for their efficacy in people with CFS who are walking. Based on evidence from multiple randomized clinical trials (RCTs), a systematic review published in the Journal of the Royal Society of Medicine (October 2006) stated that CBT and GET interventions showed promising results, appearing to reduce symptoms and improve function. The review stated that the evidence of effectiveness was inconclusive for most other interventions, with some reporting significant adverse effects. The wide variety of outcome measures used in CFS research was found to be a "fundamental problem" for assessing the effectiveness of interventions in general, and no intervention has proven to be effective in restoring the ability to work. There are no Food and Drug Administration (FDA) approved medications for ME/CFS<unk> , although medications are used without approval for the illness (off-label). Drugs have been used in experimental studies of the illness that haven't been approved for market for any condition in the United States (for example, isoprinosine and rintatolimod). Other proposed<unk> s include medical<unk> s and alternative medicine. Rintatolimod has been approved for import and use in Argentina. Even when treated, the prognosis of CFS is often poor. Recovery is "rare" even after a comprehensive rehabilitation programme.
Chronic fatigue syndrome treatment
Cancer rehabilitation
Treatment of bipolar disorder
treatment of Eating disorder
treatment of Depression 
treatment of Body image disturbance
treatment of Panic disorder
Fall prevention